Literature DB >> 2579755

Deficient immune interferon production in tuberculosis.

J K Onwubalili, G M Scott, J A Robinson.   

Abstract

Production of interferon (IFN)-alpha and -gamma by peripheral blood mononuclear cells (PBMC) were studied in 28 patients with active tuberculosis and 28 healthy control subjects matched for age, sex, ethnic origin and diet. No significant differences were found between patients and matched controls in mean titres of IFN-alpha induced by Newcastle disease virus, IFN-gamma induced by staphylococcal enterotoxin A with tetrahydrophorbyl acetate, and IFN-gamma induced by purified protein derivative (PPD). However, a subset of nine out of 25 tuberculosis patients tested produced low titres (less than 100 u/ml) of IFN-gamma in response to PBMC stimulation with PPD. In comparison to other patients, this group was characterized by lower IFN-alpha and IFN-gamma responses to virus and mitogens respectively, relative anergy to tuberculin skin testing, depressed in vitro PBMC proliferative responses to PPD, and neutrophil leucocytosis. In all nine patients effective chemotherapy restored cutaneous reactivity, PBMC proliferative responses, neutrophil counts and IFN-alpha responses to virus by 6 months, and also IFN-gamma responses to PPD in one patient re-tested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579755      PMCID: PMC1577119     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunity.

Authors:  L B Epstein; M J Cline; T C Merigan
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

2.  Quantitative aspects of the stimulation of lymphocytes by tuberculin purified protein derivative.

Authors:  C F Hinz; T M Daniel; G L Baum
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

3.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes.

Authors:  P Katz; R A Goldstein; A S Fauci
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

6.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. VI. Polyoma virus infection.

Authors:  I Gresser; C Maury; C Kress; D Blangy; M T Maunoury
Journal:  Int J Cancer       Date:  1979-08       Impact factor: 7.396

7.  Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.

Authors:  M E Kleinhenz; J J Ellner; P J Spagnuolo; T M Daniel
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types.

Authors:  S P Singh; N K Mehra; H B Dingley; J N Pande; M C Vaidya
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

9.  Increase in T cells bearing IgG Fc receptors in peripheral blood of patients with tuberculosis by in vitro stimulation with purified protein derivative.

Authors:  I Tsuyuguchi; H Shiratsuchi; O Teraoka; T Hirano
Journal:  Am Rev Respir Dis       Date:  1980-06

10.  Tuberculous meningitis: immune reactions within the central nervous system.

Authors:  J Kinnman; A Frydén; S Eriksson; E Möller; H Link
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

View more
  15 in total

1.  A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozco-Esteves; H A Maldonado; D Aguilar-León; M M Vilchis-Landeros; D A Mata-Espinosa; V Mendoza; F López-Casillas
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  A longitudinal study of gamma-interferon production by peripheral blood mononuclear cells from breast- and bottle-fed infants.

Authors:  S Stephens; S W Duffy; C Page
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Limiting dilution analysis of T cell unresponsiveness to mycobacteria in advanced disseminated tuberculosis.

Authors:  M S Gilardini Montani; F Del Gallo; G Lombardi; P Del Porto; E Piccolella; F Arienzo; V Colizzi
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

4.  Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria.

Authors:  U Greinert; M Schlaak; S Rüsch-Gerdes; H D Flad; M Ernst
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

5.  Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.

Authors:  J Vilcek; A Klion; D Henriksen-DeStefano; A Zemtsov; D M Davidson; M Davidson; A E Friedman-Kien; J Le
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

6.  Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.

Authors:  Edhyana Sahiratmadja; Bachti Alisjahbana; Tjitske de Boer; Iskandar Adnan; Anugrah Maya; Halim Danusantoso; Ronald H H Nelwan; Sangkot Marzuki; Jos W M van der Meer; Reinout van Crevel; Esther van de Vosse; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

7.  Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  M Torres; T Herrera; H Villareal; E A Rich; E Sada
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.

Authors:  H M Surcel; M Troye-Blomberg; S Paulie; G Andersson; C Moreno; G Pasvol; J Ivanyi
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

9.  Monocyte-derived IL-5 reduces TNF production by Mycobacterium tuberculosis-specific CD4 T cells during SIV/M. tuberculosis coinfection.

Authors:  Collin R Diedrich; Joshua T Mattila; JoAnne L Flynn
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

10.  Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes.

Authors:  B J Johnson; D N McMurray
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.